Interpreting Serological Tests in Diagnosing Autoimmune Liver Diseases
The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
Abstract
Autoimmune liver diseases (ALD) are characterized by immune-mediated injury of bile ducts or hepatocytes, thus including cholangiopathies such as primary biliary cirrhosis (PBC), primary sclerosing cholangitis, and autoimmune hepatitis. Further, ALD variants manifesting with both hepatocellular and cholangiocellular damage are becoming more common. Serum autoantibodies, together with imaging and histology, are critical to the diagnostic process when ALD is suspected. Because an early diagnosis can influence prognosis, the development of sensitive and specific tests for serum autoantibodies should be a priority for researchers to ensure a more efficient noninvasive workup. Little prognostic value has been observed for any of the ALD serum hallmarks, and a vigorous effort to investigate new and old markers should therefore be undertaken in longitudinal studies as in the recent paradigm of PBC-specific antinuclear antibodies. We review herein the numerous ALD screening tests available in routine and specialized laboratories and comment on their significance in clinical practice.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Immunofluorescent staining of nuclear dots (suggesting anti-sp100 reactivity) and perinuclear rims (suggesting anti-gp210 reactivity) are useful in the diagnosis of PBC in the 5-10% (depending on the assay) of patients with PBC who are AMA negative [37,[51][52][53][54].”
From EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. (2017) · cites this paper as [52]
In the citing paper
“AMA positivity is observed in more than 90% of patients with PBC [51]; immunofluorescence [1/40, or immunoenzymatic reactivity observed during cholestatic serum liver testing, is highly specific to the disease [52].”
From EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. (2017) · cites this paper as [52]
In the citing paper
“Immunofluorescent staining of nuclear dots (suggesting anti-sp100 reactivity) and perinuclear rims (suggesting anti-gp210 reactivity) are useful in the diagnosis of PBC in the 5-10% (depending on the assay) of patients with PBC who are AMA negative [37,[51][52][53][54].”
From EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. (2017) · cites this paper as [52]
In the citing paper
“immunofluorescence [1/40, or immunoenzymatic reactivity observed during cholestatic serum liver testing, is highly specific to the disease [52].”
From EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. (2017) · cites this paper as [52]
Citations
Cites
Alvarez, F., Berg, P. A., Bianchi, F. B., Bianchi, L., Burroughs, A. K., Cancado, E. L., Chapman, R. W., Cooksley, W. G. E., Czaja, A. J., Desmet, V. J., et al. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80297-9 · Cited by 2,903
High Serum IgG4 Concentrations in Patients with Sclerosing Pancreatitis
Hamano, H., Kawa, S., Horiuchi, A., Unno, H., Furuya, N., Akamatsu, T., Fukushima, M., Nikaido, T., Nakayama, K., Usuda, N., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103083441005 · Cited by 2,705
Meeting report: International autoimmune hepatitis group
Johnson, P. J., & McFarlane, I. G. (1993) · Hepatology · doi:10.1002/hep.1840180435 · Cited by 1,090
Multiplexed particle-based flow cytometric assays
Vignali, D. A. A. (2000) · Journal of Immunological Methods · doi:10.1016/s0022-1759(00)00238-6 · Cited by 913
Prognosis in primary biliary cirrhosis: Model for decision making
Dickson, R. E., Grambsch, P. M., Fleming, T. R., Fisher, L. D., & Langworthy, A. (1989) · Hepatology · doi:10.1002/hep.1840100102 · Cited by 816
(2015) · Diagnostic Imaging: Gastrointestinal · doi:10.1016/b978-0-323-37755-3.50202-6 · Cited by 811
Gregorio, G. (2001) · Hepatology · doi:10.1053/jhep.2001.22131 · Cited by 692
Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis
Wies, I., Brunner, S., Henninger, J., Herkel, J., Kanzler, S., zum Büschenfelde, K.-H. M., & Lohse, A. W. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02166-8 · Cited by 636
Homberg, J.-C., Abuaf, N., Bernard, O., Islam, S., Alvarez, F., Khalil, S. H., Poupon, R., Darnis, F., Lévy, V.-G., Grippon, P., et al. (1987) · Hepatology · doi:10.1002/hep.1840070626 · Cited by 576
Lapierre, P., Hajoui, O., Homberg, J.-C., & Alvarez, F. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70186-1 · Cited by 538
Antinuclear Antibodies in Primary Biliary Cirrhosis
Invernizzi, P., Selmi, C., Ranftler, C., Podda, M., & Wesierska-Gadek, J. (2005) · Seminars in Liver Disease · doi:10.1055/s-2005-916321 · Cited by 480
Self-citationManns, M. P., Griffin, K. J., Sullivan, K. F., & Johnson, E. F. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115443 · Cited by 456
Invernizzi, P., Podda, M., Battezzati, P. M., Crosignani, A., Zuin, M., Hitchman, E., Maggioni, M., Meroni, P. L., Penner, E., & Wesierska-Gadek, J. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(00)00040-4 · Cited by 455
Self-citationVergani, D., Alvarez, F., Bianchi, F. B., Cançado, E. L. R., Mackay, I. R., Manns, M. P., Nishioka, M., & Penner, E. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.08.002 · Cited by 446 · cited 1×
“Serum Autoantibodies in AIH In 2004, a subcommittee of the International Autoimmune Hepatitis Group established procedures and reference guidelines for more reliable serum autoantibody testing to overcome the previous lack of standardization.(9) Although tests for serum ANA, SMA, and LKM are critical for the diagnosis…”
BackgroundPrimary sclerosing cholangitis
Lawson, A. (2014) · Radiopaedia.org · doi:10.53347/rid-26818 · Cited by 443
Manns, M., Kyriatsoulis, A., Gerken, G., Staritz, M., Meyer, K. H., & Büschenfelde, Z. (1987) · The Lancet · doi:10.1016/s0140-6736(87)92024-1 · Cited by 424
Natural history of early primary biliary cirrhosis
Metcalf, J. V., Mitchison, H. C., Palmer, J. M., Jones, D. E., Bassendine, M. F., & James, O. F. (1996) · The Lancet · doi:10.1016/s0140-6736(96)04410-8 · Cited by 421
Management of primary biliary cirrhosis
Heathcote, J. E. (2000) · Hepatology · doi:10.1053/he.2000.5984 · Cited by 417
Nakamura, M., Kondo, H., Mori, T., Komori, A., Matsuyama, M., Ito, M., Takii, Y., Koyabu, M., Yokoyama, T., Migita, K., et al. (2007) · Hepatology · doi:10.1002/hep.21472 · Cited by 365
Duerr, R. H., Targan, S. R., Landers, C. J., Larusso, N. F., Lindsay, K. L., Wiesner, R. H., & Shanahan, F. (1991) · Gastroenterology · doi:10.1016/0016-5085(91)70028-v · Cited by 357
Mechanism and biological significance of CD44 cleavage
Nagano, O., & Saya, H. (2004) · Cancer Science · doi:10.1111/j.1349-7006.2004.tb03179.x · Cited by 325
Invernizzi, P., Crosignani, A., Battezzati, P. M., Covini, G., De Valle, G., Larghi, A., Zuin, M., & Podda, M. (1997) · Hepatology · doi:10.1002/hep.510250507 · Cited by 293
Self-citationRelationship of Inflammatory Bowel Disease and Primary Sclerosing Cholangitis
Fausa, O., Schrumpf, E., & Elgjo, K. (1991) · Seminars in Liver Disease · doi:10.1055/s-2008-1040420 · Cited by 282
Primary biliary cirrhosis: an orchestrated immune response against epithelial cells
Gershwin, M. E., Ansari, A. A., Mackay, I. R., Nakanuma, Y., Nishio, A., Rowley, M. J., & Coppel, R. L. (2000) · Immunological Reviews · doi:10.1034/j.1600-0528.2002.017402.x · Cited by 277
Ma, Y., Okamoto, M., Thomas, M. G., Bogdanos, D. P., Lopes, A. R., Portmann, B., Underhill, J., Dürr, R., Mieli-Vergani, G., & Vergani, D. (2002) · Hepatology · doi:10.1053/jhep.2002.32092 · Cited by 271
Prince, M. I., Chetwynd, A., Craig, W. L., Metcalf, J. V., & James, O. F. W. (2004) · Gut · doi:10.1136/gut.2003.023937 · Cited by 261
Elevated Serum IgG4 Concentration in Patients with Primary Sclerosing Cholangitis
Jaffe, D. L. (2007) · Yearbook of Gastroenterology · doi:10.1016/s0739-5930(08)70051-5 · Cited by 251
Microsomal antibodies in active chronic hepatitis and other disorders.
Rizzetto, M., Swana, G. T., & Doniach, D. (1973) · PubMed · Cited by 248
Primary Sclerosing Cholangitis, Inflammatory Bowel Disease, and Colon Cancer
Broomé, U., & Bergquist, A. (2006) · Seminars in Liver Disease · doi:10.1055/s-2006-933561 · Cited by 244
JENNE, D. E., TSCHOPP, J., LÜDEMANN, J., UTECHT, B., & GROSS, W. L. (1990) · Nature · doi:10.1038/346520a0 · Cited by 232
The Variant Forms of Autoimmune Hepatitis
Czaja, A. J. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-7-199610010-00009 · Cited by 211
Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis
Muratori, P., Muratori, L., Ferrari, R., Cassani, F., Bianchi, G., Lenzi, M., Rodrigo, L., Linares, A., Fuentes, D., & Bianchi, F. B. (2003) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.07257.x · Cited by 204
Van de Water, J., Cooper, A., Surh, C. D., Coppel, R., Danner, D., Ansari, A., Dickson, R., & Gershwin, M. E. (1989) · New England Journal of Medicine · doi:10.1056/nejm198905253202104 · Cited by 201
High-titer antineutrophil cytoplasmic antibodies in type-1 autoimmune hepatitis
Targan, S. R., Landers, C., Vidrich, A., & Czaja, A. J. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90215-5 · Cited by 199
Kaya, M., Angulo, P., & Lindor, K. D. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80004-5 · Cited by 193
Frequency and Significance of Antibodies to Actin in Type 1 Autoimmune Hepatitis
Czaja, A. J., Cassani, F., Cataleta, M., Valentini, P., & Bianchi, F. B. (1996) · Hepatology · doi:10.1002/hep.510240515 · Cited by 189
Seibold, F., Weber, P., Klein, R., Berg, P. A., & Wiedmann, K. H. (1992) · Gut · doi:10.1136/gut.33.5.657 · Cited by 184
Classification of smooth muscle autoantibodies detected by immunofluorescence.
Bottazzo, G. F., Florin-Christensen, A., Fairfax, A., Swana, G., Doniach, D., & Groeschel-Stewart, U. (1976) · Journal of Clinical Pathology · doi:10.1136/jcp.29.5.403 · Cited by 184
Baeres, M., Herkel, J., Czaja, A. J., Wies, I., Kanzler, S., Cancado, E. L. R., Porta, G., Nishioka, M., Simon, T., Daehnrich, C., et al. (2002) · Gut · doi:10.1136/gut.51.2.259 · Cited by 184
Terjung, B., Spengler, U., Sauerbruch, T., & Worman, H. J. (2000) · Gastroenterology · doi:10.1053/gast.2000.9366 · Cited by 182
Autoimmune Hepatitis, From Mechanisms to Therapy
Manns, M. P., & Vogel, A. (2006) · Hepatology · doi:10.1002/hep.21059 · Cited by 180
Behavior and significance of autoantibodies in type 1 autoimmune hepatitis
Czaja, A. J. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80096-8 · Cited by 180
Correlation of initial autoantibody profile and clinical outcome in primary biliary cirrhosis
Wesierska-Gadek, J., Penner, E., Battezzati, P. M., Selmi, C., Zuin, M., Hitchman, E., Worman, H. J., Gershwin, E. M., Podda, M., & Invernizzi, P. (2006) · Hepatology · doi:10.1002/hep.21172 · Cited by 177
Self-citationOertelt, S., Rieger, R., Selmi, C., Invernizzi, P., Ansari, A. A., Coppel, R. L., Podda, M., Leung, P. S. C., & Gershwin, E. M. (2007) · Hepatology · doi:10.1002/hep.21583 · Cited by 168
Self-citationSerum autoantibodies in patients with primary sclerosing cholangitis
Angulo, P., Peter, J. B., Gershwin, M. E., DeSotel, C. K., Shoenfeld, Y., Ahmed, A. E. E., & Lindor, K. D. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80061-6 · Cited by 167
ANTICYTOPLASMIC ANTIBODIES IN WEGENER'S GRANULOMATOSIS
Gross, W. L., Lüdemann, G., Kiefer, G., & Lehmann, H. (1986) · The Lancet · doi:10.1016/s0140-6736(86)91820-9 · Cited by 166
Etiopathogenesis of Primary Sclerosing Cholangitis
O'Mahony, C. A., & Vierling, J. M. (2006) · Seminars in Liver Disease · doi:10.1055/s-2006-933559 · Cited by 156
A murine model of type 2 autoimmune hepatitis: Xenoimmunization with human antigens
Lapierre, P., Djilali-Saiah, I., Vitozzi, S., & Alvarez, F. (2004) · Hepatology · doi:10.1002/hep.20109 · Cited by 156
Naor, D., & Nedvetzki, S. (2003) · Arthritis Research · doi:10.1186/ar746 · Cited by 151
Czaja, A. (2002) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(01)04041-2 · Cited by 142
Primary Sclerosing Cholangitis and Cholangiocarcinoma
Lazaridis, K. N., & Gores, G. J. (2006) · Seminars in Liver Disease · doi:10.1055/s-2006-933562 · Cited by 136
Autoimmune cholangitis within the spectrum of autoimmune liver disease
Czaja, A. J., Carpenter, H. A., Santrach, P. J., & Moore, B. S. (2000) · Hepatology · doi:10.1053/jhep.2000.7878 · Cited by 136
Nakamura, M., Shimizu‐Yoshida, Y., Takii, Y., Komori, A., Yokoyama, T., Ueki, T., Daikoku, M., Yano, K., Matsumoto, T., Migita, K., et al. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.11.016 · Cited by 136
Rigopoulou, E. I., Davies, E. T., Pares, A., Zachou, K., Liaskos, C., Bogdanos, D.-P., Rodes, J., Dalekos, G. N., & Vergani, D. (2005) · Gut · doi:10.1136/gut.2003.036558 · Cited by 134
Xu, B., Broome, U., Ericzon, B.-G., & Sumitran-Holgersson, S. (2002) · Gut · doi:10.1136/gut.51.1.120 · Cited by 124
Czaja, A. J., Nishioka, M., MORSHED, S. A., & Hachiya, T. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90078-7 · Cited by 122
Yamamoto, A., Cresteil, D., Homberg, J. C., & Álvarez, F. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90657-x · Cited by 120
Muratori, L., Cataleta, M., Muratori, P., Lenzi, M., & Bianchi, F. B. (1998) · Gut · doi:10.1136/gut.42.5.721 · Cited by 118
ITOH, S., ICHIDA, T., YOSHIDA, T., HAYAKAWA, A., UCHIDA, M., TASHIRO‐ITOH, T., MATSUDA, Y., ISHIHARA, K., & ASAKURA, H. (1998) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.1998.01553.x · Cited by 118
Biopsy Findings and Clinical Correlations
Burgart, L. J., Batts, K. P., Ludwig, J., Nikias, G. A., & Czaja, A. J. (1995) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199506000-00010 · Cited by 102
Anti-Saccharomyces cerevisiae antibodies (ASCA) and autoimmune liver diseases
MURATORI, P., MURATORI, L., GUIDI, M., MACCARIELLO, S., PAPPAS, G., FERRARI, R., GIONCHETTI, P., CAMPIERI, M., & BIANCHI, F. B. (2003) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.2003.02166.x · Cited by 102
Autoantibodies and Autoantigens in Autoimmune Hepatitis
Strassburg, C. P., & Manns, M. P. (2002) · Seminars in Liver Disease · doi:10.1055/s-2002-35704 · Cited by 101
Clinical significance of anti-neutrophil cytoplasmic antibodies (ANCA) in autoimmune liver diseases
Roozendaal, C., Jong, M. A. D., Berg, A. P. V. D., Wijk, R. T. V., Limburg, P. C., & Kallenberg, C. G. M. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80241-x · Cited by 100 · cited 1×
“A few studies have found a correlation between serum endpoint titers of antineutrophil antibodies and clinical indices in PSC, such as ANCA being associated with decreased serum albumin and increased serum alkaline phosphatase levels, so suggesting a more severe disease course.(95)”
BackgroundDrug–Induced Hepatitis Associated With Anticytoplasmic Organelle Autoantibodies
Homberg, J.-C., Abuaf, N., Helmy-Khalil, S., Biour, M., Poupon, R., Islam, S., Darnis, F., Levy, V. G., Opolon, P., Beaugrand, M., et al. (1985) · Hepatology · doi:10.1002/hep.1840050504 · Cited by 99
Terjung, B., Herzog, V., Worman, H. J., Gestmann, I., Bauer, C., Sauerbruch, T., & Spengler, U. (1998) · Hepatology · doi:10.1002/hep.510280207 · Cited by 92
Miyachi, K., Hankins, R., Matsushima, H., Kikuchi, F., Inomata, T., Horigome, T., Shibata, M., Onozuka, Y., Ueno, Y., Hashimoto, E., et al. (2003) · Journal of Autoimmunity · doi:10.1016/s0896-8411(03)00033-7 · Cited by 92
WIENCKE, K., SPURKLAND, A., SCHRUMPF, E., & BOBERG, K. (2001) · Hepatology · doi:10.1053/jhep.2001.25743 · Cited by 89
Mulder, A. H. L., Broekroelofs, J., Horst, G., Limburg, P. C., Nelis, G. F., & Kallenberg, C. G. M. (1994) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1994.tb07024.x · Cited by 87
Lenzi, M., Manotti, P., Muratori, L., Cataleta, M., Ballardini, G., Cassani, F., & Bianchi, F. B. (1995) · Gut · doi:10.1136/gut.36.5.749 · Cited by 87
Primary Sclerosing Cholangitis: Epidemiology, Natural History, and Prognosis
Levy, C., & Lindor, K. D. (2006) · Seminars in Liver Disease · doi:10.1055/s-2006-933560 · Cited by 84
The peculiar autoimmunity of primary biliary cirrhosis
Mackay, I. R., Whittingham, S., Fida, S., Myers, M., Ikuno, N., & Gershwin, M. E. (2000) · Immunological Reviews · doi:10.1034/j.1600-0528.2002.017410.x · Cited by 84
Yang, W.-H., Yu, J. H., Nakajima, A., Neuberg, D., Lindor, K., & Bloch, D. B. (2004) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00465-3 · Cited by 83
The Asialoglycoprotein Receptor as Target Structure in Autoimmune Liver Diseases
Poralla, T., Treichel, U., Löhr, H. F., & Fleischer, B. (1991) · Seminars in Liver Disease · doi:10.1055/s-2008-1040439 · Cited by 82
The immunobiology of primary sclerosing cholangitis
Aoki, C. A., Bowlus, C. L., & Gershwin, M. E. (2004) · Autoimmunity Reviews · doi:10.1016/j.autrev.2004.09.003 · Cited by 81
Muratori, L., Lenzi, M., Yuan-fang Ma, A., Cataleta, M., Mieli‐Vergani, G., Vergani, D., & Bianchi, F. B. (1995) · Gut · doi:10.1136/gut.37.3.406 · Cited by 78
Anti-neutrophil antibodies in primary sclerosing cholangitis
Terjung, B., & Worman, H. J. (2001) · Best Practice & Research Clinical Gastroenterology · doi:10.1053/bega.2001.0209 · Cited by 75
Effective Use of Autoantibody Tests in the Diagnosis of Systemic Autoimmune Disease
Lyons, R., Narain, S., Nichols, C., Satoh, M., & Reeves, W. H. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1313.023 · Cited by 75
Smooth Muscle Antibodies and Type 1 Autoimmune Hepatitis
Muratori, P., Muratori, L., Agostinelli, D., Pappas, G., Veronesi, L., Granito, A., Cassani, F., Terlizzi, P., Lenzi, M., & Bianchi, F. B. (2002) · Autoimmunity · doi:10.1080/0891693021000054066 · Cited by 74
The Medical Management of Primary Sclerosing Cholangitis
Cullen, S. N., & Chapman, R. W. (2006) · Seminars in Liver Disease · doi:10.1055/s-2006-933563 · Cited by 70
Treichel, U., Gerken, G., Rossol, S., Rotthauwe, H. W., Büschenfelde, K. H. M. Z., & Poralla, T. (1993) · Journal of Hepatology · doi:10.1016/s0168-8278(05)80176-x · Cited by 68
Fine specificity of autoantibodies to soluble liver antigen and liver/pancreas
Herkel, J., Heidrich, B., Nieraad, N., Wies, I., Rother, M., & Lohse, A. W. (2002) · Hepatology · doi:10.1053/jhep.2002.30699 · Cited by 63
Joshi, S. (2002) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(02)03976-x · Cited by 61
Immunopathogenesis of Primary Sclerosing Cholangitis
Worthington, J., Cullen, S., & Chapman, R. W. (2005) · Clinical Reviews in Allergy & Immunology · doi:10.1385/criai:28:2:093 · Cited by 61
Beuers, U. H. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.11.009 · Cited by 61
Yamamoto, A., Johanet, C., Duclos-Vallee, J.-C., Bustarret, F.-A., Álvarez, F., Homberg, J.-C., & Bach, J. (1997) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1997.4071302.x · Cited by 53
Strassburg, C. P., Alex, B., Zindy, A., Gerken, G., Lüttig, B., Büschenfelde, K. M. Z., Bréchot, C., & Manns, M. P. (1996) · Journal of Hepatology · doi:10.1016/s0168-8278(96)80290-x · Cited by 52
Immunopathogenesis of Primary Biliary Cirrhosis
Nishio, A., Keeffe, E. B., & Gershwin, M. E. (2002) · Seminars in Liver Disease · doi:10.1055/s-2002-34506 · Cited by 51
Immunological Study of Anti-M2 in Antimitochondrial Antibody-Negative Primary Biliary Cirrhosis.
KITAMI, N., KOMADA, T., ISHII, H., SHIMIZU, H., ADACHI, H., YAMAGUCHI, Y., KITAMURA, T., OIDE, H., MIYAZAKI, A., ISHIKAWA, M., et al. (1995) · Internal Medicine · doi:10.2169/internalmedicine.34.496 · Cited by 46
Neuberger, J., & Bradwell, A. R. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00322-7 · Cited by 45
Gatselis, N., Georgiadou, S. P., Koukoulis, G. Κ., Tassopoulos, N. C., Zachou, K., Liaskos, C., Hatzakis, A. E., & Dalekos, G. Ν. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03165.x · Cited by 42
The Immune Response to Mitochondrial Autoantigens
Ishibashi, H., Shimoda, S., & Gershwin, M. E. (2005) · Seminars in Liver Disease · doi:10.1055/s-2005-916325 · Cited by 37
Chazouillères, O. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80021-5 · Cited by 34
Immunological Liver Diseases in Children
Mieli‐Vergani, G., & Vergani, D. (1998) · Seminars in Liver Disease · doi:10.1055/s-2007-1007163 · Cited by 33
Mattalia, A., Lüttig, B., Rosina, F., Leung, P. S. C., Van de Water, J., Bauducci, M., Ciancio, A., Böker, K. H. W., Worman, H., Cooper, R. L., et al. (1997) · Journal of Autoimmunity · doi:10.1006/jaut.1997.0156 · Cited by 32
Leucocyte activation by anti-lactoferrin antibodies bound to vascular endothelium
Peen, E., Sundqvist, T., & Skogh, T. (1996) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1996.tb08294.x · Cited by 24
Muratori, L., Muratori, P., Granito, A., Ferrari, R., Veronesi, L., Lenzi, M., & Bianchi, F. B. (2004) · Digestive and Liver Disease · doi:10.1016/j.dld.2004.09.019 · Cited by 22
Antinuclear Antibody (ANA) Patterns in Hepatic and Extrahepatic Autoimmune Disease
Strassburg, C. P., & Manns, M. P. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80358-4 · Cited by 18
Chronic active hepatitis in childhood with detection of liver-pancreas-specific autoantibodies
Teufel, M., Niessen, K. H., & Berg, P. A. (1983) · European Journal of Pediatrics · doi:10.1007/bf00661901 · Cited by 14
Antiphospholipid syndrome in combination with autoimmune hepatitis
Hueber, A. J., Boxberger, F., Ganslmayer, M., & Hahn, E. G. (2005) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200502000-00017 · Cited by 9
Invernizzi, P., Wesierska-Gadek, J., Battezzati, P. M., Oertelt‐Prigione, S., Busatto, P., Benetti, A., Penner, E., Hitchman, E., & Podda, M. (2004) · Journal of Hepatology · doi:10.1016/s0168-8278(04)90544-2 · Cited by 7
Self-citation
Cited by
EASL Clinical Practice Guidelines: management of cholestatic liver diseases
European Association for the Study of the Liver (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.04.009 · Cited by 1,729
“Immunological markers: The diagnostic hallmark of PBC is the presence of AMA, which are detected in serum of more than 90% of affected individuals; the specificity of AMA in PBC is greater than 95% [8].”
BackgroundHirschfield, G. M., Beuers, U., Corpechot, C., Invernizzi, P., Jones, D., Marzioni, M., & Schramm, C. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.03.022 · Cited by 1,480
Self-citationCarbone, M., Sharp, S. J., Flack, S., Paximadas, D., Spiess, K., Adgey, C., Griffiths, L., Lim, R., Trembling, P., Williamson, K., et al. (2016) · Hepatology · doi:10.1002/hep.28017 · Cited by 354
“Consistent with other recent series,((7,18,19)) approximately 10% of participants had”
Primary biliary cholangitis: pathogenesis and therapeutic opportunities
Gulamhusein, A. F., & Hirschfield, G. M. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0226-7 · Cited by 308
Autoimmune liver serology: Current diagnostic and clinical challenges
Bogdanos, D. P., Invernizzi, P., Mackay, I. R., & Vergani, D. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.3374 · Cited by 213
Self-citation
Metadata
- Authors
- Invernizzi, P., Lleo, A., & Podda, M.
- Affiliations
- University of Milan (IT)
- Venue
- Seminars in Liver Disease
- Publisher
- Georg Thieme Verlag KG
- Published
- 2007-05
- Volume
- 27
- Issue
- 2
- Pages
- 161-172
- ISSN
- 0272-8087 (ISSN-L)
- 1098-8971
- OpenAlex
- W2057559137
- Semantic Scholar
- 0a58fc9710d003122ddfa2675fd15232d706cbb4
- Cited by
- 107
- References
- 100
- Citations by year
- 2025: 5 · 2023: 4 · 2022: 2 · 2021: 3 · 2020: 5 · 2019: 4 · 2018: 4 · 2017: 6 · 2016: 2 · 2015: 3 · 2014: 7 · 2013: 13 · 2012: 12
- FWCI
- 6.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Seminars in Liver Disease (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
- Health Sciences › Medicine › Rheumatology › IgG4-Related and Inflammatory Diseases
- Keywords
- autoimmune liver disease, serological tests, serum autoantibodies, primary biliary cirrhosis, primary sclerosing cholangitis, autoimmune hepatitis, antinuclear antibodies, diagnostic biomarkers, non-invasive diagnosis, screening test
- MeSH terms
- Animals, Autoantibodies, Autoimmune Diseases, Humans, Liver Cirrhosis, Biliary, Mass Screening, Predictive Value of Tests, Sensitivity and Specificity, Cholangitis, Sclerosing, Biomarkers, Hepatitis, Autoimmune
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.